December 2021, Inflamalps announces that Innosuisse, the Swiss fund for Innovation granted CHF650’000 to a consortium led by Inflamalps and comprising the University of Turin in Italy, the University of Canterbury in New Zealand, the Haute Ecole d'ingénierie et d’architecture de Fribourg in Switzerland, the microbiology specialized CRO IHMA in Switzerland and the Mass Spectrometry Platform at Chemistry Institute at the EPFL, Switzerland, to identify the active molecules in several biological extracts showing remarkable anti-microbial activities previously identified in a screening campaign. The project was initiated 1st December 2021. See press release.